- CollPlant
- Raziel Therapeutics
- TPCera
- Omnix Medical
- Eximore
![]() |
Collplant Ltd. is a Biomaterials start-up company which developed a method of producing collagen in transgenic tobacco plants. This method of production based on the extraction of cultivated tobacco plants carrying the human collagen genes P4H and LH3, and other tobacco plants carrying C/N proteinases http://www.collplant.com |
![]() |
TPCera develops a new type of immunomodulatory compound that shifts the immune system from an inflammatory state into an anti-inflammatory one. |
![]() |
Omnix Medical is developing new antimicrobial agents to fight resistant bacteria and to win the battle against Antibiotic Resistance. Bringing a new strategy against resistant bacteria Omnix is developing the next generation of antibiotic drugs. https://www.omnixmedical.com |
![]() |
Eximore is developing ophthalmic drug delivery products. The company’s initial development is a non-invasive, novel sustained-release delivery system targeting glaucoma. |